United Therapeutics Corporation (UTHR)

NMS – Real Time Price. Currency in USD

511.10

-4.40 (-0.85%)

At close: Aug 12, 2026, 3:59 PM EDT

511.72

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3.18B

2.88B

2.33B

1.94B

Cost of goods sold

-384M

-310M

-258M

-152M

Gross Profit

2.80B

2.57B

2.07B

1.78B

Operating expenses (excl. COGS)

-1.28B

-1.19B

-882M

-794M

Operating Income

1.52B

1.38B

1.19B

991M

Non-operating income, total

197M

162M

86M

-40M

Pretax income

1.71B

1.54B

1.27B

951M

Equity in earnings

Taxes

-379M

-344M

-290M

-223M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

1.33B

1.20B

985M

727M

Discontinued operations

Net income

1.33B

1.20B

985M

727M

Dilution adjustment

Preferred dividends

United Therapeutics Corporation (UTHR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

United Therapeutics Corporation (UTHR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

United Therapeutics Corporation (UTHR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

United Therapeutics Corporation (UTHR)

Income Statement (Annual)

Income Statement (Annual)